fbpx
News
April 25, 2017

In the News Today – April 25, 2017

First Xarelto Case to Test Views Over Attorney Drug Ads: Yesterday marks the start of the first bellwether trial over blood thinner Xarelto in New Orleans.  Xarelto has “become the poster child for critics of unbridled plaintiffs’ attorney advertising” because these ads invite meritless cases and the dire warnings put patients at risk by convincing them to stop taking their medications. “Xarelto is just one of the potential examples,” said Harold Kim, executive vice president for the Institute of Legal Reform. “With Xarelto, there’s naturally some comparable data that underscores the concerns.” (The National Law Journal)

U.S. Attorney General Sessions Puts White-Collar Focus on Individual Prosecution: During an event yesterday in Washington, D.C. Attorney General Jeff Sessions said that good companies don’t need to be punished because “one person went awry.” Additionally, AG Sessions noted that “a company cannot be a guarantor that any of its thousands, perhaps, employees never do something wrong.” Sessions also said the DOJ will continue to enforce the Foreign Corrupt Practices Act. (The National Law Journal)  

Checklist News FCPA Enforcement, Compliance Trends During The Pandemic COVID-19 Liability, Foreign Corrupt Practices Act (FCPA) Video Watch the Recording of ILR Briefly Live Event: COVID-19 State Liability Issues and Solutions Foreign Corrupt Practices Act (FCPA), Medical Liability, Securities Litigation Reform, Telephone Consumer Protection Act (TCPA) News In the News Today - March 15, 2019 Foreign Corrupt Practices Act (FCPA), Over-Enforcement News FCPA Self-Reporting Program Makes Headway Foreign Corrupt Practices Act (FCPA), Over-Enforcement Blog Department of Justice Changes Its Ephemeral Messaging Policy Foreign Corrupt Practices Act (FCPA)

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings